Attached files
| file | filename |
|---|---|
| EX-31.1 - EXHIBIT 31.1 - BIOCRYST PHARMACEUTICALS INC | exh_311.htm |
| 10-K/A - FORM 10-K/A - BIOCRYST PHARMACEUTICALS INC | f10ka_032718.htm |
Exhibit 31.2
SECTION 302 CERTIFICATION
I, Thomas R. Staab II, certify that:
| 1. | I have reviewed this Amendment No. 1 on Form 10-K/A to the Annual Report on Form 10-K for the year ending December 31, 2017 of BioCryst Pharmaceuticals, Inc. |
| 2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report. |
Date: March 27, 2018
/s/ Thomas R. Staab II
Thomas R. Staab II
Chief Financial Officer and Treasurer
(Principal Financial Officer)